History, genetic, and recent advances on Krabbe disease

Gene

Volumn 555, Issue 1, 2015, Pages 2-13

  Graziano, Adriana Carol Eleonora ^a   Cardile, Venera ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Globoid cell leukodystrophy; Lysosomal storage disease; Myelin; Sphingolipid; Galactocerebrosidase

Indexed keywords

GALACTOSYLCERAMIDASE; GALACTOSYLCERAMIDE; PSYCHOSINE;

AMINO ACID SEQUENCE; BONE MARROW TRANSPLANTATION; CHORION VILLUS; DNA LIBRARY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME REPLACEMENT; GENE MUTATION; GENE THERAPY; GLOBOID CELL LEUKODYSTROPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN SITU HYBRIDIZATION; LINKAGE ANALYSIS; MACROPHAGE; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PSYCHOMOTOR ACTIVITY; REVIEW; TANDEM MASS SPECTROMETRY; WHITE MATTER; ANIMAL; GENETICS; HISTORY; LEUKODYSTROPHY, GLOBOID CELL; PATHOPHYSIOLOGY;

CANIS FAMILIARIS; MACACA MULATTA; MUS; OVIS ARIES;

ANIMALS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; LEUKODYSTROPHY, GLOBOID CELL;

EID: 84919338176     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.09.046     Document Type: Review

References (158)

1. Austin J.H., Lehfeldt D. Studies in globoid (Krabbe) leukodystrophy. III. Significance of experimentally-produced globoid-like elements in rat white matter and spleen. J. Neuropathol. Exp. Neurol. 1965, 24:265-289.
2. Baskin G.B., Ratterree M., Davison B.B., Falkenstein K.P., Clarke M.R., England J.D., Vanier M.T., Luzi P., Rafi M.A., Wenger D.A. Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe disease) in rhesus monkeys (Macaca mulatta). Lab. Anim. Sci. 1998, 48:476-482.
3. Belleri M., Ronca R., Coltrini D., Nico B., Ribatti D., Poliani P.L., Giacomini A., Alessi P., Marchesini S., Santos M.B., Bongarzone E.R., Presta M. Inhibition of angiogenesis by b-galactosylceramidase deficiency in globoid cell leukodystrophy. Brain 2013, 136:2859-2875.
4. Berardi A.S., Pannuzzo G., Graziano A., Costantino-Ceccarini E., Piomboni P., Luddi A. Pharmacological chaperones increase residual β-galactocerebrosidase activity in fibroblasts from Krabbe patients. Mol. Genet. Metab. 2014, 112:294-301.
5. Biswas S., LeVine S.M. Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy. Pediatr. Res. 2002, 51:40-47.
6. Biswas S., Biesiada H., Williams T.D., LeVine S.M. Substrate reduction intervention by l-cycloserine in twitcher mice (globoid cell leukodystrophy) on a B6;CAST/Ei background. Neurosci. Lett. 2003, 347:33-36.
7. Blakemore K., Hattenburg C., Stetten G., Berg K., South S., Murphy K., Jones R. In utero hematopoietic stem cell transplantation with haploidentical donor adult bone marrow in a canine model. Am. J. Obstet. Gynecol. 2004, 190:960-973.
8. Borda J.T., Alvarez X., Mohan M., Ratterree M.S., Phillippi-Falkenstein K., Lackner A.A., Bunnell B.A. Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy. Am. J. Pathol. 2008, 172:98-111.
9. Cannizzaro L.A., Chen Y.Q., Rafi M., Wenger D.A. Regional mapping of the human galactocerebrosidase gene (GALC) to 14q31 by in situ hybridization. Cytogenet. Cell Genet. 1994, 66:244-245.
10. Cantuti-Castelvetri L., Zhu H., Givogri M.I., Chidavaenzi R.L., Lopez-Rosas A., Bongarzone E.R. Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases. Neurobiol. Dis. 2012, 46:325-335.
11. Canuti-Castelvetri L., Givogri M.I., Zhu H., Smith B., Lopez-Rosas A., Qiu X., Bongarzone E.R. Axonopathy is a compounding factor in the pathogenesis of Krabbe disease. Acta Neuropathol. 2011, 122:35-48.
12. Chen Y.Q., Wenger D.A. Galactocerebrosidase from human urine: purification and partial characterization. Biochim. Biophys. Acta 1993, 1170:53-61.
13. Chen Y.Q., Rafi M.A., De Gala G., Wenger D.A. Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Hum. Mol. Genet. 1993, 2:1841-1845.
14. Christie William W. Ceramide Monohexosides: Structure, Occurrence, Biosynthesis and Analysis 2011, 1-8. In lipidlibrary.aocs.org.
15. Contreras M.A., Haq E., Uto T., Singh I., Singh A.K. Psychosine-induced alterations in peroxisomes of twitcher mouse liver. Arch. Biochem. Biophys. 2008, 477:211-218.
16. Costantino-Ceccarini E., Morell P. Biosynthesis of brain sphingolipids and myelin accumulation in the mouse. Lipids 1972, 7:656-659.
17. Costantino-Ceccarini E., Luddi A., Volterrani M., Strazza M., Rafi M.A., Wenger D.A. Transduction of cultured oligodendrocytes from normal and twitcher mice by a retroviral vector containing human galactocerebrosidase (GALC) cDNA. Neurochem. Res. 1999, 24:287-293.
18. Croitoru-Lamoury J., Williams K.R., Lamoury F.M., Veas L.A., Ajami B., Taylor R.M., Brew B.J. Neural transplantation of human MSC and NT2 cells in the twitcher mouse model. Cytotherapy 2006, 8:445-458.
19. D'Agostino A.N., Sayre G.P., Hayles A.B. Krabbe's disease: globoid cell type of leukodystrophy. Arch. Neurol. 1963, 8:82-96.
20. De Gasperi R., Gama Sosa M.A., Sartorato E.L., Battistini S., MacFarlane H., Gusella J.F., Krivit W., Kolodny E.H. Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy. Am. J. Hum. Genet. 1996, 59:1233-1242.
21. De Gasperi R., Gama Sosa M.A., Sartorato E., Battistini S., Raghavan S., Kolodny E.H. Molecular basis of late-life globoid cell leukodystrophy. Hum. Mutat. 1999, 14:256-262.
22. Deane J.E., Graham S.C., Na Kim N., Stein P.E., McNair R., Begoña Cachón-González M., Cox T.M., Read R.J. Insights into Krabbe disease from structures of galactocerebrosidase. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15169-15173.
23. Debs R., Froissart R., Aubourg P., Papeix C., Douillard C., Degos B., Fontaine B., Audoin B., Lacour A., Said G., Vanier M.T., Sedel F. Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J. Inherit. Metab. Dis. 2013, 36:859-868.
24. Desnick R.J., Schuchman E.H. Enzyme replacement and enhancement therapies: lessons from lysosomal disorders. Nat. Rev. Genet. 2002, 3:954-966.
25. Duchen L.W., Eicher E.M., Jacobs J.M., Scaravilli F., Teixeira F. Hereditary leukodystrophy in the mouse: the new mutant twitcher. Brain 1980, 103:695-710.
26. Escolar M.L., Poe M.D., Provenzale J.M., Richards K.C., Allison J., Wood S., Wenger D.A., Pietryga D., Wall D., Champagne M., Morse R., Krivit W., Kurtzberg J. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N. Engl. J. Med. 2005, 352:2069-2081.
27. Fiumara A., Barone R., Arena A., Filocamo M., Lissens W., Pavone L., Sorge G. Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation. Clin. Genet. 2011, 80:452-458.
28. Fletcher T.F., Kurtz H.J. Animal model: globoid cell leukodystrophy in the dog. Am. J. Pathol. 1972, 66:375-378.
29. Fletcher J., Williamson P., Taylor R. Krabbe disease in the Australian working Kelpie. Orbit 2009, 1:57-74.
30. Formichi P., Radi E., Battisi C., Pasqui A., Pompella G., Lazzerini P.E., Laghi-pasini F., Leonini A., Steffano A.D., Federico A. Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. J. Cell. Physiol. 2007, 212:737-743.
31. Fu L., Inui K., Nishigaki T., Tatsumi N., Tsukamoto H., Kokubu C., Muramatsu T., Okada S. Molecular heterogeneity of Krabbe disease. J. Inherit. Metab. Dis. 1999, 22:155-162.
32. Furuya H., Kukita Y., Nagano S., Sakai Y., Yamashita Y., Fukuyama H., Inatomi Y., Saito Y., Koike R., Tsuji S., Fukumaki Y., Hayashi K., Kobayashi T. Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients. Hum. Genet. 1997, 100:450-456.
33. Galbiati F., Givogri M.I., Cantuti L., Rosas A.L., Cao H., van Breemen R., Bongarzone E.R. Combined hematopoietic and lentiviral gene-transfer therapies in newborn twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease. J. Neurosci. Res. 2009, 87:1748-1759.
34. Gama Sosa M.A., De Gasperi R., Undevia S., Yeretsian J., Rouse S.C., Lyerla T.A., Kolodny E.H. Correction of the galactocerebrosidase deficiency in globoid cell leukodystrophy-cultured cells by SL3-3 retroviral-mediated gene transfer. Biochem. Biophys. Res. Commun. 1996, 218:766-771.
35. Giri S., Jatana M., Rattan R., Won J.S., Singh I., Singh A.K. Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease. FASEB J. 2002, 16:661-672.
36. Giri S., Khan M., Rattan R., Singh I., Singh A.K. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death. J. Lipid Res. 2006, 47:1478-1492.
37. Giri S., Khan N., Nath N., Singh T., Singh A. The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease. J. Neurochem. 2008, 105:1820-1833.
38. Hagberg B., Sourander P., Svennerholm L. Diagnosis of Krabbe's infantile leukodystrophy. J. Neurol. Neurosurg. Psychiatry 1963, 26:195-198.
39. Hagberg B., Kollberg H., Sourander P., Akesson H. Infantile globoid cell leukodystrophy (Krabbe's disease). A clinical and genetic study of 32 Swedish cases 1953-1967. Neuropadiatrie 1969, 1:74-88.
40. Hannun Y.A., Bell R.M. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 1987, 235:670-674.
41. Haq E., Giri S., Singh I., Singh A.K. Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J. Neurochem. 2003, 86:1428-1440.
42. Haq E., Contreras M.A., Giri S., Singh I., Singh A.K. Dysfunction of peroxisomes in twitcher mice brain: a possible mechanism of psychosine-induced disease. Biochem. Biophys. Res. Commun. 2006, 343:229-238.
43. Harzer K., Scuster I. Prenatal enzymatic diagnosis and exclusion of Krabbe's disease (globoid-cell leukodystrophy) using chorionic villi: pitfalls in the use of uncultured villi. Hum. Genet. 1989, 84:83-85.
44. Harzer K., Hager H.D., Tariverdian G. Prenatal enzymatic diagnosis and exclusion of Krabbe's disease (globoid-cell leukodystrophy) using chorionic villi in five risk pregnancies. Hum. Genet. 1987, 77:342-344.
45. Hawkins-Salsbury J.A., Parameswar A.R., Jiang X., Schlesinger P., Bongarzone E., Ory D.S., Demchenko A.V., Sands M.S. Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture. J. Lipid Res. 2013, 54:3303-3311.
46. Hoogerbrugge P.M., Suzuki K., Suzuki K., Poorthuis B.J., Kobayashi T., Wagemaker G., van Bekkum D.W. Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science 1988, 239:1035-1038.
47. Hossain M.A., Otomo T., Saito S., Ohno K., Sakuraba H., Hamada Y., Ozono K., Sakai N. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form. Gene 2014, 534:144-154.
48. Ichioka T., Kishimoto Y., Brennan S., Santos G.W., Yeager A.M. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:4259-4263.
49. Igisu H., Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 1984, 224:753-755.
50. Ijichi K., Brown G.D., Moore C.S., Lee J.P., Winokur P.N., Pagarigan R., Snyder E.Y., Bongarzone E.R., Crocker S.J. MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology. Glia 2013, 61:765-777.
51. Im D.S., Heise C.E., Nguyen T., O'Dowd B.F., Lynch K.R. Identification of a molecular target of psychosine and its role in globoid cell formation. J. Cell Biol. 2001, 153:429-434.
52. Jacob J.C., Kutty K.M., Islam M., Dominic R.G., Dawson G. Krabbe's disease: globoid cell leukodystrophy. Can. Med. Assoc. J. 1973, 108:1398-1400.
53. Jatana M., Giri S., Singh A.K. Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci. Lett. 2002, 330:183-187.
54. Kanazawa T., Nakamura S., Momoi M., Yamaji T., Takematsu H., Yano H., Sabe H., Yamamoto A., Kawasaki T., Kozutsumi Y. Inhibition of cytokinesis by a lipid metabolite, psychosine. J. Cell Biol. 2000, 149:943-950.
55. Khan M., Haq E., Giri S., Singh I., Singh A.K. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease. J. Neurosci. Res. 2005, 80:845-854.
56. Kleijer W.J., van der Keulemans J.L.M., Kraan M., Geilen G.G., van der Helm R.M., Rafi M.A., Luzi P., Wenger D.A., Halley D.J.J., van Diggelen O.P. Prevalent mutations in the GALC gene of patients with Krabbe disease of Dutch and other European origin. J. Inherit. Metab. Dis. 1997, 20:587-594.
57. Kobayashi T., Yamanaka T., Jacobs J.M., Teixeira F., Suzuki K. The twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Res. 1980, 202:479-483.
58. Kobayashi T., Shinnoh N., Goto I., Kuroiwa Y. Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid beta-galactosidases. J. Biol. Chem. 1985, 260:14982-14987.
59. Kolter T., Sandhoff K. Sphingolipid metabolism diseases. Biochim. Biophys. Acta 2006, 1758:2057-2079.
60. Kozutsumi Y., Kanazawa T., Sun Y., Yamaji T., Yamamoto H., Takematsu H. Sphingolipids involved in the induction of multinuclear cell formation. Biochim. Biophys. Acta 2002, 1582:138-143.
61. Krabbe K.A. New familial, infantile form of diffuse brain-sclerosis. Brain 1916, 39:74-114.
62. Krivit W., Shapiro E.G., Peters C., Wagner J.E., Cornu G., Kurtzberg J., Wenger D.A., Kolodny E.H., Vanier M.T., Loes D.J., Dusenbery K., Lockman L.A. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N. Engl. J. Med. 1998, 338:1119-1126.
63. Krivit W., Aubourg P., Shapiro E., Peters C. Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr. Opin. Hematol. 1999, 6:377-382.
64. Krivit W., Peters C., Shapiro E.G. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr. Opin. Neurol. 1999, 12:167-176.
65. Kukita Y., Furuya H., Kobayashi T., Sakai N., Hayashi K. Characterization of the GALC gene in three Japanese patients with adult-onset Krabbe disease. Genet. Test. 1997-1998, 1:217-223.
66. Lattanzi A., Salvagno C., Maderna C., Benedicenti F., Morena F., Kulik W., Naldini L., Montini E., Martino S., Gritti A. Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy. Hum. Mol. Genet. 2014, 23:3250-3268.
67. Lee W.C., Courtenay A., Troendle F.J., Stallings-Mann M.L., Dickey C.A., DeLucia M.W., Dickson D.W., Eckman C.B. Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy. FASEB J. 2005, 19:1549-1551.
68. Lee W.C., Tsoi Y.K., Troendle F.J., DeLucia M.W., Ahmed Z., Dicky C.A., Dickson D.W., Eckman C.B. Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy. FASEB J. 2007, 21:2520-2527.
69. Lefebvre S., Vartanian T. Molecular basis of myelin. Disorders of Myelin in the Central and Peripheral Nervous Systems. Chapter 2 2002, Butterworth Heinemann, Woburn. F. Dangond, B. Heinemann (Eds.).
70. LeVine S.M., Brown D.C. IL-6 and TNFalpha expression in brains of twitcher, quaking and normal mice. J. Neuroimmunol. 1997, 73:47-56.
71. LeVine S.M., Wetzel D.L., Eilert A.J. Neuropathology of twitcher mice-examination by histochemistry, immunohistochemistry and Fourier-transform infrared microspectroscopy. Int. J. Dev. Neurosci. 1994, 12:275-288.
72. LeVine S.M., Pedchenko T.V., Bronshteyn I.G., Pinson D.M. l-Cycloserine slows the clinical and pathological course in mice with globoid cell leukodystrophy (twitcher mice). J. Neurosci. Res. 2000, 60:231-236.
73. Lin D., Fantz C.R., Levy B., Rafi M.A., Vogler C., Wenger D.A., Sands M.S. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2. Mol. Ther. 2005, 12:422-430.
74. Lin D., Donsante A., Macauley S., Levy B., Vogler C., Sands M.S. Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy. Mol. Ther. 2007, 15:44-52.
75. Lissens W., Arena A., Seneca S., Rafi M., Sorge G., Liebaers I., Wenger D., Fiumara A. A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region. Hum. Mutat. 2007, 28:742.
76. Loes D.J., Peters C., Krivit W. Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. AJNR Am. J. Neuroradiol. 1999, 20:316-323.
77. Luddi A., Volterrani M., Strazza M., Smorlesi A., Rafi M.A., Datto J., Wenger D.A., Costantino-Ceccarini E. Retrovirus-mediated gene transfer and galactocerebrosidase uptake into twitcher glial cells results in appropriate localization and phenotype correction. Neurobiol. Dis. 2001, 8:600-610.
78. Luzi P., Rafi M.A., Wenger D.A. Structure and organization of the human galactocerebrosidase (GALC) gene. Genomics 1995, 26:407-409.
79. Luzi P., Rafi M.A., Wenger D.A. Multiple mutations in the GALC gene in a patient with adult-onset Krabbe disease. Ann. Neurol. 1996, 40:116-119.
80. Luzi P., Rafi M.A., Victoria T., Baskin G.B., Wenger D.A. Characterisation of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate. Genomics 1997, 42:319-324.
81. Luzi P., Rafi M.A., Zaka M., Curtis M., Vanier M.T., Wenger D.A. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease). Mol. Genet. Metab. 2001, 73:211-223.
82. Luzi P., Rafi M.A., Zaka M., Rao H.Z., Curtis M., Vanier M.T., Wenger D.A. Biochemical and pathological evaluation of long-lived mice with globoid cell leukodystrophy after bone marrow transplantation. Mol. Genet. Metab. 2005, 86:150-159.
83. Lyon G., Hagberg B., Evrard P., Allaire C., Pavone L., Vanier M. Symptomatology of late onset Krabbe's leukodystrophy: the European experience. Dev. Neurosci. 1991, 13:240-244.
84. Maghazachi A.A., Knudsen E., Jin Y., Jenstad M., Chaudhry F.A. d-Galactosyl-beta1-1'-sphingosine and d-glucosyl-beta1-1'-sphingosine induce human natural killer cell apoptosis. Biochem. Biophys. Res. Commun. 2004, 320:810-815.
85. Martin J.J., Leroy J.G., Ceuterick C., Libert J., Dodinval P., Martin L. Fetal Krabbe leukodystrophy: a morphologic study of two cases. Acta Neuropathol. 1981, 53:87-91.
86. Matsuda J., Suzuki K. Krabbe disease (globoid cell leukodystrophy). Lysosomal Storage Disorders 2007, 269-283. Springer, US. J.A. Barranger, M. Cabrera-Salazar (Eds.).
87. Matsuda J., Vanier M.T., Saito Y., Tohyama J., Suzuki K., Suzuki K. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene causes a late-onset, slowly progressive form of globoid cell leukodystrophy in the mouse. Hum. Mol. Genet. 2001, 10:1191-1199.
88. McGowan J.C., Haskins M., Wenger D.A., Vite C. Investigating demyelination in the brain in a canine model of globoid cell leukodystrophy (Krabbe disease) using magnetization transfer contrast: preliminary results. J. Comput. Assist. Tomogr. 2000, 24:316-321.
89. McGraw R.A., Carmichael K.P. Molecular basis of globoid cell leukodystrophy in Irish setters. Vet. J. 2006, 171:370-372.
90. Miller S.L., Denisova L. Cycloserine-induced decrease of cerebroside in myelin. Lipids 1998, 33:441-443.
91. Miyatake T., Suzuki K. Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase. Biochem. Biophys. Res. Commun. 1972, 48:538-543.
92. Miyatake T., Suzuki K. Galactosylsphingosine galactosyl hydrolase. Partial purification and properties of the enzyme in the rat brain. J. Biol. Chem. 1972, 247:5398-5403.
93. Mohri I., Taniike M., Okazaki I., Kagitani-Shimono K., Aritake K., Kanekiyo T., Yagi T., Takikita S., Kim H.S., Urade Y., Suzuki K. Lipocalin-type prostaglandin D synthase is up-regulated in oligodendrocytes in lysosomal storage diseases and binds gangliosides. J. Neurochem. 2006, 97:641-651.
94. Mohri I., Taniike M., Taniguchi H., Kanekiyo T., Aritake K., Inui T., Fukumoto N., Eguchi N., Kushi A., Sasai H., Kanaoka Y., Ozono K., Narumiya S., Suzuki K., Urade Y. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J. Neurosci. 2006, 26:4383-4393.
95. Online Mendelian Inheritance in Man, OMIM (TM) 2007, Johns Hopkins University, Baltimore, MD, MIM Number: 245200: 2007: World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/.
96. Pannuzzo G., Cardile V., Costantino-Ceccarini E., Alvares E., Mazzone D., Perciavalle V. A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice. Mol. Genet. Metab. 2010, 100:234-240.
97. Parenti G. Treating lysosomal storage diseases with pharmacological chaperones: from concepts to clinics. EMBO Mol. Med. 2009, 1:268-279.
98. Platt F.M., Lachmann R.H. Treating lysosomal storage disorders: current practice and future prospects. Biochim. Biophys. Acta 2009, 1793:7337-7345.
99. Platt F.M., Walkley S.U. Lysosomal Disorders of the Brain: Recent Advances in Molecular and Cellular Pathogenesis and Treatment 2004, Oxford Univ. Press, Oxford. F.M. Platt, S.U. Walkley (Eds.).
100. Pritchard D.H., Napthine D.V., Sinclair A.J. Globoid cell leukodystrophy in polled Dorset sheep. Vet. Pathol. 1980, 17:399-405.
101. Qin E.Y., Hawkins-Salsbury J.A., Jiang X., Reddy A.S., Farber N.B., Ory D.S., Sands M.S. Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy. Mol. Genet. Metab. 2012, 107:186-196.
102. Rafi M.A., Luzi P., Chen Y.Q., Wenger D.A. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease. Hum. Mol. Genet. 1995, 4:1285-1289.
103. Rafi M.A., Fugaro J., Amini S., Luzi P., de Gala G., Victoria T., Dubell C., Shahinfar M., Wenger D.A. Retroviral vector-mediated transfer of the galactocerebrosidase (GALC) cDNA leads to overexpression and transfer of GALC activity to neighboring cells. Biochem. Mol. Med. 1996, 58:142-150.
104. Rafi M.A., Luzi P., Zlotogora J., Wenger D.A. Two different mutations are responsible for Krabbe disease in the Druze and Moslem Arab populations in Israel. Hum. Genet. 1996, 97:304-308.
105. Rafi M.A., Zhi Rao H., Passini M.A., Curtis M., Vanier M.T., Zaka M., Luzi P., Wolfe J.H., Wenger D.A. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy. Mol. Ther. 2005, 11:734-744.
106. Rafi M.A., Rao H.Z., Luzi P., Curtis M.T., Wenger D.A. Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease. Mol. Ther. 2012, 20:2031-2042.
107. Sakai N., Inui K., Fujii N., Fukushima H. Krabbe disease: isolation and characterization of a full-length cDNA for human galactocerebrosidase. Biochem. Biophys. Res. Commun. 1994, 198:485-491.
108. Sakai N., Tatsumi N., Fukushima H., Nishigaki T., Taniike M., Nishimoto J., Tsukamoto H., Yanagihara I., Ozono K., Okada S. Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease. J. Neurochem. 1996, 66:1118-1124.
109. Shen J.S., Watabe K., Ohashi T., Eto Y. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements. Gene Ther. 2001, 8:1081-1087.
110. Smith B., Galbiati F., Castelvetri L.C., Givogri M.I., Lopez-Rosas A., Bongarzone E.R. Peripheral neuropathy in the twitcher mouse involves the activation of axonal caspase 3. ASN Neuro 2011, 3:e00066.
111. Smith B., Santos M., Marshall M., Cantuti-Castelvetri L., Lopez-Rosas A., Guannan L., van Breemen R., Claycomb K., Gallea J., Celej M., Crocker S.J., Givogri M., Bongarzone E.R. Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease. J. Pathol. 2014, 232:509-521.
112. Spiegel R., Bach G., Sury V., Mengistu G., Meidan B., Shalev S., Shneor Y., Mandel H., Zeigler M. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. Mol. Genet. Metab. 2005, 84:160-166.
113. Starr C., Taggart R. Animal structure and function. Biology: The Unity and Diversity of Life 2001, Brooks/Cole division of Thompson Learning Inc., Pacific Grove, CA. 11th ed.
114. Sundaram K.S., Lev M. Inhibition of sphingolipid synthesis by cycloserine in vitro and in vivo. J. Neurochem. 1984, 42:577-581.
115. Sundaram K.S., Lev M. The long-term administration of l-cycloserine to mice: specific reduction of cerebroside level. Neurochem. Res. 1989, 14:245-248.
116. Suzuki K. Twenty five years of the psychosine hypothesis: a personal perspective of its history and present status. Neurochem. Res. 1998, 23:251-259.
117. Suzuki K. Evolving perspective of the pathogenesis of globoid cell leukodystrophy (Krabbe disease). Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2003, 79:1-8.
118. Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J. Child Neurol. 2003, 18:595-603.
119. Suzuki K. Krabbe disease. Myelin Biology and Disorders 2004, 841-850. Elsevier/Academic Press, San Diego, CA. R.A. Lazzarini, H. Lassman, K.A. Nave, R. Miller, B. Trapp (Eds.).
120. Suzuki K. Krabbe disease. Myelin Biology and Disorders 2004, 1101-1113. Elsevier/Academic Press, San Diego, CA. R.A. Lazzarini, H. Lassman, K.A. Nave, R. Miller, B. Trapp (Eds.).
121. Suzuki K., Suzuki Y. Globoid cell leukodystrophy (Krabbe's disease): deficiency of galactocerebroside β-galactosidase. Proc. Natl. Acad. Sci. U. S. A. 1970, 66:302-309.
122. Suzuki Y., Suzuki K. Krabbe's globoid cell leukodystrophy: deficiency of galactocerebrosidase in serum, leukocytes, and fibroblasts. Science 1971, 171:73-75.
123. Suzuki K., Suzuki K. The twitcher mouse. A model of human globoid cell leukodystrophy (Krabbe's disease). Am. J. Pathol. 1983, 111:394-397.
124. Suzuki K., Suzuki K. Genetic galactosylceramidase deficiency (globoid cell leukodystrophy, Krabbe disease) in different mammalian species. Neurochem. Pathol. 1985, 3:53-68.
125. Suzuki K., Tanaka H., Suzuki K. Studies on the pathogenesis of Krabbe's leukodystrophy: cellular reaction of the brain to exogenous galactosylsphingosine, monogalactosyl diglyceride and lactosylceramide. Current Trends in Sphingolipidoses and Allied Disorders 1976, 99-113. Plenum Press, New York. B.W. Volk, L. Schneck (Eds.).
126. Svennerholm L., Vanier M.T., Mansson J.E. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J. Lipid Res. 1980, 21:53-64.
127. Taketomi T., Nishimura K. Physiological activity of psychosine. Jpn. J. Exp. Med. 1964, 34:255-265.
128. Taniike M., Mohri I., Eguchi N., Irikura D., Urade Y., Okada S., Suzuki K. An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy. J. Neuropathol. Exp. Neurol. 1990, 58:644-653.
129. Tapasi S., Padma P., Setty O.H. Effect of psychosine on mitochondrial function. Indian J. Biochem. Biophys. 1998, 35:161-165.
130. Tappino B., Biancheri R., Mort M., Regis S., Corsolini F., Rossi A., Stroppiano M., Lualdi S., Fiumara A., Bembi B., Di Rocco M., Cooper D.N., Filocamo M. Identification and characterization of 15 novel GALC gene mutation causing Krabbe disease. Hum. Mutat. 2010, 31:E1894-E1914.
131. Tatsumi N., Inui K., Sakai N., Fukushima H., Nishimoto J., Yanagihara I., Nishigaki T., Tsukamoto H., Fu L., Taniike M., Okada S. Molecular defects in Krabbe disease. Hum. Mol. Genet. 1995, 4:1865-1868.
132. Tohyama J., Matsuda J., Suzuki K. Psychosine is as potent as inducer of cell death as C6-ceramide in cultured fibroblasts and in MOCH-1 cells. Neurochem. Res. 2001, 26:667-671.
133. Vanier M.T., Svennerholm L. Chemical pathology of Krabbe's disease. I. Lipid composition and fatty acid patterns of phosphoglycerides in brain. Acta Paediatr. Scand. 1974, 63:494-500.
134. Vanier M.T., Svennerholm L. Chemical pathology of Krabbe's disease. III. Ceramide hexosides and gangliosides of brain. Acta Paediatr. Scand. 1975, 64:641-648.
135. Vanier M.T., Svennerholm L. Chemical pathology of Krabbe disease: the occurrence of psychosine and other neutral sphingoglycolipids. Current Trends in Sphingolipidoses and Allied Disorders 1976, 115-126. Plenum Press, New York. B. Volk, L. Schneck (Eds.).
136. Vanier M.T., Svennerholm L., Månsson J.E., Håkansson G., Boué A., Lindsten J. Prenatal diagnosis of Krabbe disease. Clin. Genet. 1981, 20:79-89.
137. Victoria T., Rafi M.A., Wenger D.A. Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers. Genomics 1996, 33:457-462.
138. Wenger D.A. Krabbe disease (globoid cell leukodystrophy). The Molecular and Genetic Basis of Neurological Disease 1997, 421-431. Butterworth-Heinemann, Boston. 2nd ed. R.N. Rosenberg, S. Prusiner, S. Di Mauro, R.L. Barchi (Eds.).
139. Wenger D.A. Krabbe disease. GeneReviews® [Internet] 2000, University of Washington, Seattle (WA), (Jun 19 [Updated 2011 Mar 31], 1993-2014. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1238/). R.A. Pagon, M.P. Adam, H.H. Ardinger (Eds.).
140. Wenger D.A. Disease models murine, canine and non-human primate models of Krabbe disease. Mol. Med. Today 2000, 6:449-451.
141. Wenger D.A., Rafi M.A., Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum. Mutat. 1997, 10:268-279.
142. Wenger D.A., Victoria T., Rafi M.A., Luzi P., Vanier M.T., Vite C., Patterson D.F., Haskins M.H. Globoid cell leukodystrophy in cairn and West Highland white terriers. J. Hered. 1999, 90:138-142.
143. Wenger D.A., Rafi M.A., Luzi P., Datto J., Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy. Mol. Genet. Metab. 2000, 70:1-9.
144. Wenger D.A., Rafi M.A., Luzi P., Costantino-Ceccherini E. Krabbe disease: genetic aspects and progress toward therapy. Mol. Genet. Metab. 2000, 70:1-9.
145. Wenger D.A., Suzuki K., Suzuki Y., Suzuki K. Chapter 147: galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease). Metabolic and Molecular Basis of Inherited Disease 2001, McGraw-Hill, New York. C.R. Scriver, A.L. Beauder, W.S. Sly, D. Valle (Eds.).
146. Wenger D.A., Coppola S., Shu-Ling Liu B.S. Insights into the diagnosis and treatment of lysosomal storage diseases. Arch. Neurol. 2003, 60:322-328.
147. White A.B., Givogri M.I., Lopez-Rosas A., Cao H., van Breemen R., Thinakaran G., Bongarzone E.R. Psychosine accumulates in membrane microdomains in the brain of Krabbe patients, disrupting the raft architecture. J. Neurosci. 2009, 29:6068-6077.
148. White A.B., Galbiati F., Givogri M.I., Lopez Rosas A., Qiu X., van Breemen R., Bongarzone E.R. Persistence of psychosine in brain lipid rafts is a limiting factor in the therapeutic recovery of a mouse model for Krabbe disease. J. Neurosci. Res. 2011, 89:352-364.
149. Whitfield P.D., Sharp P.C., Taylor R., Meikle P. Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry. J. Lipid Res. 2001, 42:2092-2095.
150. Xu C., Sakai N., Taniike M., Inui K., Ozono K. Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation. J. Hum. Genet. 2006, 51:548-554.
151. Yamada H., Martin P., Suzuki K. Impairment of protein kinase C activity in twitcher Schwann cells in vitro. Brain Res. 1996, 718:138-144.
152. Yeager A.M., Brennan S., Tiffany C., Moser H.W., Santos G.W. Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science 1984, 225:1052-1054.
153. Yunis E.J., Lee R.E. The ultrastructure of globoid (Krabbe) leukodystrophy. Lab. Invest. 1969, 21:415-419.
154. Zafini A., Dreassi E., Berardi A., Governini L., Corbini G., Costantino-Ceccarini E., Balestri P., Luddi A. Quantification of psychosine in the serum of twitcher mouse by LC-ESI-tandem-MS analysis. J. Pharm. Biomed. Anal. 2013, 80:44-49.
155. Zaka M., Wenger D.A. Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation. Neurosci. Lett. 2004, 358:205-209.
156. Zaka M., Rafi M.A., Rao H.Z., Luzi P., Wenger D.A. Insulin-like growth factor-1 provides protection against psychosine-induced apoptosis in cultured mouse oligodendrocyte progenitor cells using primarily the PI3K/Akt pathway. Mol. Cell. Neurosci. 2005, 30:398-407.
157. Zizioli D., Guarienti M., Tobia C., Gariano G., Borsani G., Bresciani R., Ronca R., Giacopuzzi E., Preti A., Gaudenzi G., Belleri M., Di Salle E., Fabrias G., Casas J., Ribatti D., Monti E., Presta M. Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease. Biochim. Biophys. Acta 1842, 2014:665-675.
158. Zoglotora J., Chakraborty S., Knowlton R., Wenger D.A. Krabbe disease locus mapped to chromosome 14 by genetic linkage. Am. J. Hum. Genet. 1990, 47:37-44.